Genting to develop first stem cell facility in Bali, expand into healthcare
Fontaine Vitale will be the first in Asean to offer placenta-derived allogeneic stem cell therapy
Add BT as a preferred source
[KUALA LUMPUR] Malaysian conglomerate Genting has launched its first stem cell facility in Bali, Indonesia, marking a significant milestone in its expansion into advanced healthcare and medical tourism.
The Fontaine Vitale facility, located in the Sanur Special Economic Zone (SEZ), will be operated by Genting’s 56-per-cent-owned indirect subsidiary Astana Bangun Sejahtera, in partnership with Indonesian companies Sentosa Bersama Mitra and Bintang Graha Hijau.
Fontaine Vitale will also collaborate with US-based Celularity to integrate cutting-edge expertise in cellular and regenerative medicine, bringing advanced therapies and treatments to the region.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Family office for US$12 billion Tetra Pak Fortune exits Hong Kong
Deloitte’s Lee Boon Teck succeeds Teo Ser Luck as president of Singapore’s national accounting body
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
